Alan Auerbach - Berkeley Law
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Puma Biotechnology - Overview, News & Competitors | ZoomInfo.com
PBYI: Puma Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg
Shareholders to Recover $55 Million in Rare Jury Verdict
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Puma FY 2020_Proxy
Part 2: Alan Auerbach President & CEO Puma Biotech - YouTube
Barry Simon vs Alan Auerbach | Comparably
Alan H. Auerbach Net Worth (2023) | wallmine
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Biotech Entrepreneur's Fortune Nearly Doubles After Strong Clinical Trials For Cancer Treatment
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Neratinib Improves PFS in HER2+ Metastatic Breast Cancer
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Local Executive Pay Experiences Recovery - Los Angeles Business Journal
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Highest-Paid Chiefs in 2014 - The New York Times
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
Puma Biotechnology CEO And Leadership: Executives and Demographics - Zippia
DEFA14A
Alan H. Auerbach - CEO, President & Chairman at Puma Biotechnology | The Org
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Back Up on FDA OK - Los Angeles Business Journal
